CLOSE X

SANOFI CONSUMER HEALTHCARE INDIA LTD.

NSE : SANOFICONRBSE : 544250ISIN CODE : INE0UOS01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE4799.15124.25 (+2.66 %)
PREV CLOSE ( ) 4674.90
OPEN PRICE ( ) 4819.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4056
TODAY'S LOW / HIGH ( )4694.60 4941.20
52 WK LOW / HIGH ( )3950.5 5954
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 10-05 2023
Management Info
Amit Jain - Chairman Himanshu Bakshi - Managing Director
Registered Office

Address Unit 1104, 11th Floor, Godrej Two,Pirojshanagar, Eastern Express Highway,Vikhroli (East),
Mumbai,
Maharashtra-400079

Phone 022 45288855

Email igrc.schil@sanofi.com

Website www.sanofi.in

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
28Apr Sanofi Consumer Healthcare India infor
With reference to its letter dated 23rd April 2026 informing its Board M..
27Mar Sanofi Consumer Healthcare India infor
Sanofi Consumer Healthcare India has informed that it enclosed transcrip..
26Feb Sanofi Consumer Healthcare India’s net
Sanofi Consumer Healthcare India has reported results for fourth quarter..
20Feb Sanofi Consumer Healthcare India submi
Sanofi Consumer Healthcare India has informed that this is with referenc..
10Oct Sanofi Consumer Healthcare India inf
In accordance with Regulation 30 of the SEBI (Listing Obligations and Di..
Financials
Rs. in Millions
QTR Mar 26 ANNUAL 25
Net Profit6782401
Gross Profit 907 3203
Operating Profit 9443274
Net Sales 22928784
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 14652.50 (1.44%)
M.Cap ( in Cr)18798.99
Emcure Pharma (BSE)
 1732.85 (7.69%)
M.Cap ( in Cr)32853.02
Abbott India (BSE)
 25484.55 (0.47%)
M.Cap ( in Cr)54152.89
Divi's Lab (BSE)
 6535.00 (1.57%)
M.Cap ( in Cr)173483.72
Concord Biotech (BSE)
 1131.90 (5.68%)
M.Cap ( in Cr)11841.51
Shareholding Pattern
PROMOTERS 71.27%
MUTUAL FUNDS/UTI 13.63%
NON-INSTITUTION 8.4%
FI/BANKS/INSURANCE 3.94%
FII 0.01%
GOVERNMENT 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data February 2026 Broking Complaints Data February 2026 DP

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal(https://scores.sebi.gov.in/)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.